Dublin, June 11, 2020 (GLOBE NEWSWIRE) -- The "COVID-19 Diagnostics - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

The Global COVID-19 Diagnostics market accounted for $16.13 billion in 2018 and is expected to reach $31.18 billion by 2027 growing at a CAGR of 7.6% during the forecast period. Rise in the number of cases of COVID-19 patients across the globe and requirement to ensure accurate test results are the major factors driving the market growth. However, lack of knowledge about the coronavirus, its symptoms, and its ability to spread is restraining the market growth.

COVID-19 is an infectious disease caused due to the coronavirus. Its symptoms include mild to moderate respiratory discomfort. While most may recover without any need for special treatment, the virus can cause major issues or serious illness and even death in older individuals and persons with underlying medical problems such as diabetes and cancers. As it has been the cause of numerous deaths, and infections in the past there is an urgent need for accurate diagnostic methods.

Based on test type, the molecular segment is likely to have a huge demand as it involves the extraction of viral RNA from a patient's sample and synthesis of the complementary DNA (cDNA) followed by amplification of the viral genome. By geography, North America is going to have a lucrative growth during the forecast period due to the well-established healthcare system and several pharmaceutical companies.

Some of the key players profiled in the COVID-19 Diagnostics Market include Alveo Technologies, Accelerate Diagnostics, Abbott Diagnostics, Aus Diagnostics, Ador Diagnostics, Akkoni Biosystems, Applied BioCode, BD Diagnostics, Cue Health, Biocartis, Co-Diagnostics, BioFire Diagnostics, Cepheid, bioMerieux, Bosch Healthcare Solutions GmbH, Bio-Rad Laboratories, Curetis, GenePOC Diagnostics, Diagenode Diagnostics and GenMark Dx.

Quantity of Users Covered:

Test Types Covered:

End Users Covered:

Regions Covered:

North America

Europe

Asia Pacific

South America

Middle East & Africa

What the report offers:

Key Topics Covered:

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global COVID-19 Diagnostics Market, By Quantity of User
5.1 Introduction
5.2 Multiple
5.3 Single

6 Global COVID-19 Diagnostics Market, By Test Type
6.1 Introduction
6.2 Serology
6.3 Molecular

7 Global COVID-19 Diagnostics Market, By End User
7.1 Introduction
7.2 Public Health Labs
7.3 Private or Commercial Labs
7.4 Physician Labs
7.5 Hospitals

8 Global COVID-19 Diagnostics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Alveo Technologies
10.2 Accelerate Diagnostics
10.3 Abbott Diagnostics
10.4 Aus Diagnostics
10.5 Ador Diagnostics
10.6 Akkoni Biosystems
10.7 Applied BioCode
10.8 BD Diagnostics
10.9 Cue Health
10.10 Biocartis
10.11 Co-Diagnostics
10.12 BioFire Diagnostics
10.13 Cepheid
10.14 bioMerieux
10.15 Bosch Healthcare Solutions GmbH
10.16 Bio-Rad Laboratories
10.17 Curetis
10.18 GenePOC Diagnostics
10.19 Diagenode Diagnostics
10.20 GenMark Dx

For more information about this report visit https://www.researchandmarkets.com/r/pf52tq

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. 

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900